Trials / Completed
CompletedNCT01886690
A Study to Compare the Safety and Efficacy of a New Eye Drop Formulation With REFRESH PLUS® in Participants Following LASIK Refractive Surgery
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 148 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
This study will compare the safety and efficacy of a new eye drop formulation with REFRESH PLUS® in participants following LASIK surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | carboxymethylcellulose sodium based new eye drop formulation | 1 to 2 drops of carboxymethylcellulose sodium based New Eye Drop Formulation in each eye as per protocol for 90 days. |
| DRUG | carboxymethylcellulose sodium based eye drops | 1 to 2 drops carboxymethylcellulose sodium based (REFRESH PLUS®) eye drops in each eye as per protocol for 90 days. |
Timeline
- Start date
- 2013-08-20
- Primary completion
- 2014-08-18
- Completion
- 2014-08-18
- First posted
- 2013-06-26
- Last updated
- 2019-04-16
- Results posted
- 2015-10-05
Locations
2 sites across 2 countries: Australia, Canada
Source: ClinicalTrials.gov record NCT01886690. Inclusion in this directory is not an endorsement.